13G Filing: Baker Bros. Advisors and Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

The Adviser
GP, Felix J. Baker and Julian C. Baker as principals of the Adviser GP, and the Adviser may be deemed to be beneficial owners
of securities of the Issuer directly held by the Funds, and may be deemed to have the power to vote or direct the vote of and
the power to dispose or direct the disposition of such securities.

The Reporting
Persons disclaim beneficial ownership of the securities of the Issuer held by each of the Funds, and this Schedule 13G shall not
be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 13(d) or
for any other purpose, except to the extent that any such Reporting Persons actually exercises voting or dispositive power with
respect to such securities.

Pursuant
to the management agreements, as amended, among the Adviser, the Funds and their respective general partners, the Funds’
respective general partners relinquished to the Adviser all discretion and authority with respect to the investment and voting
power of the securities held by the Funds, and thus the Adviser has complete and unlimited discretion and authority with respect
to the Funds’ investments and voting power over investments.

If this
statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the following ¨.
N/A

The information
in Item 4 is incorporated herein by reference.

The information
in Item 4 is incorporated herein by reference.